Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial.
Saved in:
| Title: | Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial. |
|---|---|
| Authors: | Synnott, Naoise C.1 (AUTHOR), Polymeropoulos, Christos M.1 (AUTHOR) christos.polymeropoulos@vandapharma.com, Xiao, Changfu1 (AUTHOR), Birznieks, Gunther1 (AUTHOR), Polymeropoulos, Mihael H.1 (AUTHOR) |
| Source: | PLoS ONE. 9/19/2025, Vol. 20 Issue 9, p1-15. 15p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0332366 |
